An update of phase I data from RTOG 0211: A phase I/II clinical study of ZD 1839 (Gefitinib) plus radiation for newly diagnosed glioblastoma (GBM) patients

被引：0
|
作者：
Chakravarti, A
Seiferheld, W
Robins, HI
Guha, A
Brachman, D
Curran, W
Choucair, A
Mehta, M
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Amer Coll Radiol, Philadelphia, PA USA
[3] Univ Wisconsin, Madison, WI USA
[4] Univ Toronto, Toronto, ON, Canada
[5] Fdn Canc Res, Phoenix, AZ USA
[6] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[7] LDS Hosp, Salt Lake City, UT USA
来源：
NEURO-ONCOLOGY | 2004年 / 6卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：372 / 372
页数：1
相关论文
共 50 条
  • [1] An update of phase I data from RTOG 0211: A phase I/II clinical study of gefitinib plus radiation for newly-diagnosed glioblastoma (GBM) patients.
    Chakravarti, A
    Seiferheld, W
    Robins, HI
    Guha, A
    Brachman, D
    Curran, W
    Choucair, A
    Mehta, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 124S - 124S
  • [2] An update of phase II results from RTOG 0211: A phase I/II study of Gefitinib plus radiation for newly-diagnosed glioblastoma patients
    Chakravarti, A.
    Berkey, B.
    Robins, H. I.
    Guha, A.
    Curran, W.
    Brachman, D.
    Shultz, C.
    Mehta, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S83 - S84
  • [3] An update on correlative molecular Endpoints from RTOG 0211: Phase I/II study of gefitinib plus radiation for newly diagnosed glioblastoma patients
    Chakravarti, A.
    Wang, M.
    Mischel, P.
    Robins, H. I.
    Guha, A.
    Machtay, M.
    Curran, W.
    Roach, M.
    Mehta, M.
    Dicker, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S9 - S10
  • [4] AN UPDATE ON CORRELATIVE MOLECULAR ENDPOINTS FROM RTOG 0211: PHASE I/II STUDY OF GEFITINIB plus RADIATION FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Chakravartti, A.
    Wang, M.
    Mischel, P.
    Robins, H. I.
    Guha, A.
    Machray, M.
    Curran, W.
    Roach, M.
    Mehta, M.
    Dicker, A.
    NEURO-ONCOLOGY, 2008, 10 (05) : 785 - 785
  • [5] An update of phase II results from RTOG 0211: A phase I/II study of gefitinib with radiotherapy in newly diagnosed glioblastoma multiforme
    Chakravarti, A.
    Berkey, B.
    Robins, I.
    Guha, A.
    Curran, W.
    Brachman, D.
    Shultz, C.
    Mehta, M.
    NEURO-ONCOLOGY, 2006, 8 (04) : 439 - 439
  • [6] An update of phase II results from RTOG 0211: A phase I/II study of gefitinib with radiotherapy in newly diagnosed glioblastorna.
    Chakravarti, A.
    Berkey, B.
    Robins, H. I.
    Guha, A.
    Curran, W. J.
    Brachman, D.
    Shultz, C.
    Mehta, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 64S - 64S
  • [7] RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients
    Chakravarti, Arnab
    Wang, Meihua
    Robins, H. Ian
    Lautenschlaeger, Tim
    Curran, Walter J.
    Brachman, David G.
    Schultz, Christopher J.
    Choucair, Ali
    Dolled-Filhart, Marisa
    Christiansen, Jason
    Gustavson, Mark
    Molinaro, Annette
    Mischel, Paul
    Dicker, Adam P.
    Bredel, Markus
    Mehta, Minesh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (05): : 1206 - 1211
  • [8] Phase I/II study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme (GBM) or gliosarcoma
    Butowski, N. A.
    Lamborn, K.
    Chang, S.
    Thornton, D.
    DeBoer, R.
    Page, M.
    Rabbitt, J.
    Parvanateni, R.
    Kivett, V.
    Nicol, S.
    Prados, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] PHASE I/II STUDY TO EVALUATE THE SAFETY AND CLINICAL EFFICACY OF ATEZOLIZUMAB (ATEZO) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Weathers, Shiao-Pei
    Kamiya-Matsuoka, Carlos
    Harrison, Rebecca
    Liu, Diane
    Sanqui, Edmund
    Dervin, Shannon
    Yun, Cindy
    Loghin, Monica
    Penas-Prado, Marta
    Majd, Nazanin
    Yung, W. K. Alfred
    O'Brien, Barbara
    de Groot, John
    NEURO-ONCOLOGY, 2020, 22 : 35 - 35
  • [10] PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Ahluwalia, Manmeet
    Patel, Neha
    Khosla, Atulya
    Rauf, Yasmeen
    Stevens, Glen
    Murphy, Erin
    Chao, Samuel
    Yu, Jennifer
    Suh, John
    Peereboom, David
    NEURO-ONCOLOGY, 2022, 24 : 60 - 60
12345